STRUCTURAL-CHANGES OF DUODENUM BRUSH-BORDER IN LUNG-CANCER PATIENTS TREATED WITH CISPLATIN PLUS ETOPOSIDE

被引:28
作者
SARTORI, S
NIELSEN, I
TREVISANI, L
TASSINARI, D
ALEOTTI, A
GRANDI, E
ABBASCIANO, V
机构
[1] ARCISPEDALE ST ANNA,SERV ONCOL,I-44100 FERRARA,ITALY
[2] UNIV FERRARA,CTR MICROSCOPIA ELETTRON,I-44100 FERRARA,ITALY
[3] UNIV FERRARA,IST ANAT PATOL,I-44100 FERRARA,ITALY
[4] UNIV FERRARA,IST PATOL MED,I-44100 FERRARA,ITALY
关键词
BRUSH BORDER; CISPLATIN; ETOPOSIDE; LUNG CANCER; MICROVILLI;
D O I
10.1016/0169-5002(93)90309-L
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effects of cisplatin plus etoposide chemotherapy (PE) on the structure of proximal intestine villi and brush border were investigated in 10 patients with lung cancer. The day before starting chemotherapy (time 1); 8 days after its initiation (time 2), and one month after the 3rd course of PE (time 3) they underwent esophagogastroduodenoscopy and three biopsies were taken from the descending duodenum. Intestinal villi were examined by light microscopy; brush border by transmission electron microscopy. No significant histological changes of villous pattern were observed at times 2 and 3. The height of microvilli was reduced in seven patients at time 2 (P < 0.05). Microvilli abnormalities (i.e. rarefaction and/or heterogeneity in their height) were present in nine patients at time 2 (P < 0.05). Brush border appearance at time 3 did not differ from that at time 1. PE chemotherapy seems to have short-term toxic effects on small intestine brush border, but does not cause chronic enteropathy.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 20 条
[11]  
LEWIS JH, 1986, AM J GASTROENTEROL, V81, P819
[12]   SMALL BOWEL BIOPSY FOR MALABSORPTION - COMPARISON OF THE DIAGNOSTIC ADEQUACY OF ENDOSCOPIC FORCEPS AND CAPSULE BIOPSY SPECIMENS [J].
MEE, AS ;
BURKE, M ;
VALLON, AG ;
NEWMAN, J ;
COTTON, PB .
BRITISH MEDICAL JOURNAL, 1985, 291 (6498) :769-772
[13]   A COMPARISON IN RODENTS OF RENAL AND INTESTINAL TOXICITY OF CISPLATIN AND A NEW WATER-SOLUBLE ANTITUMOR PLATINUM COMPLEX - N-METHYL-IMINODIACETATO-DIAMINOCYCLOHEXANE PLATINUM (II) [J].
NEWMAN, RA ;
KHOKHAR, AR ;
SUNDERLAND, BA ;
TRAVIS, EL ;
BULGER, RE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1986, 84 (03) :454-463
[14]   TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].
OKEN, MM ;
CREECH, RH ;
TORMEY, DC ;
HORTON, J ;
DAVIS, TE ;
MCFADDEN, ET ;
CARBONE, PP .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655
[15]  
PARRILLI G, 1989, CANCER RES, V49, P3689
[16]  
SARTORI S, 1991, ONCOLOGY-BASEL, V48, P356
[17]   EXTENDING THE SCOPE IN CELIAC-DISEASE [J].
SHANAHAN, F ;
WEINSTEIN, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (12) :782-783
[18]  
SLAVIN RE, 1978, CANCER, V42, P1747, DOI 10.1002/1097-0142(197810)42:4<1747::AID-CNCR2820420413>3.0.CO
[19]  
2-T
[20]  
TRIER JS, 1962, GASTROENTEROLOGY, V43, P407